Alaunos Therapeutics Inc (FRA:WEK)
€ 1.41 0 (0%) Market Cap: 326.90 Mil Enterprise Value: 325.71 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 55/100

Q4 2022 Alaunos Therapeutics Inc Earnings Call Transcript

Mar 07, 2023 / 01:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Alaunos Therapeutics' Fourth Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Danielle Dudgeon with Stern IR. Please go ahead.

Danielle Dudgeon

Good morning, and welcome to the Alaunos Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call and Audio Webcast.

Earlier this morning, Alaunos issued a press release announcing financial results for the 3 months and full year ended December 31, 2022. We encourage everyone to read today's press release as well as the Alaunos' annual report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC this morning. The company's press release and annual report will also be available on the Alaunos' website at alaunos.com. In addition, this conference call is being webcast through the Investor Relations section of the company's website and will be archived there

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot